MedTrace Logo

Abuse Potential and Human Pharmacology of Methylone

NCT05488171 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2022-08-08

No results posted yet for this study

Summary

The purposes of the study are 1) To assess the abuse potential of methylone after controlled administration of a single oral dose of methylone 2) to evaluate subjective and physiological effects of methylone 3) to determine the pharmacokinetics parameters and metabolism of methylone.

Conditions

  • Substance Use
  • Healthy Subjects

Interventions

DRUG

Methylone

Single oral dose of 200 mg of methylone.

DRUG

3,4-methylenedioxymethamphetamine

Single oral dose of 100 mg of MDMA.

DRUG

Placebo

Single oral dose of placebo.

Sponsors & Collaborators

  • Fundació Recerca Institut Germans Trias i Pujol

    collaborator UNKNOWN

  • Istituto Superiore di Sanità

    collaborator OTHER

  • Germans Trias i Pujol Hospital

    lead OTHER

Principal Investigators

  • Magi Farré, MD, PhD · Germans Trias i Pujol Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-07-31
Completion
2022-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488171 on ClinicalTrials.gov